Show Me CKDintercept Initiative: A Collective Impact Approach to Improve Population Health in Missouri

Area of Science:

• Public Health
• Health Services Research
• Health Equity

Background:

• Chronic kidney disease (CKD) affects millions, with 90% undiagnosed and significant care disparities.
• Current CKD testing and management often fall short of established guidelines, particularly in primary care settings.

Purpose of the Study:

• To evaluate the effectiveness of a collective impact (CI) initiative, Show Me CKDintercept, aimed at improving CKD diagnosis and management in primary care.
• To assess the initiative's reach, effectiveness, adoption, implementation, and maintenance (RE-AIM) in a statewide setting.

Main Methods:

• The Show Me CKDintercept initiative utilized a data strategy, stakeholder engagement, and learning in action working groups (LAWG).
• The RE-AIM framework was employed to evaluate the initiative's success from January 2021 to June 2022 in Missouri, USA.

Main Results:

• The initiative successfully engaged 159 stakeholders from 81 organizations, fostering a sense of urgency and identifying new CKD champions.
• Adoption was significant, with 53% of participants committing to advancing the initiative's roadmap, establishing a foundation for CI in Missouri.

Conclusions:

• The CI initiative demonstrated potential in building leadership consensus and driving public health improvements for kidney disease.
• While short-term results are promising, long-term impact on the burden of CKD requires further evaluation.